Two more biopharma companies—the hair-growth specialist Veradermics and cancer-focused Eikon Therapeutics—have announced ...
WASHINGTON, Jan 8 (Reuters) - U.S. Federal Housing Finance Agency Director William Pulte said on Thursday he expects ...
Securities and exchange board of India (Sebi) Chairman Tuhin Kanta Pandey said on Saturday that the regulator is at an ...
SEBI signals NSE IPO nod by month-end as unlisted shares top Rs 2,000; stay updated on anticipated issue details.
Elon Musk’s rocket company SpaceX is bolstering its efforts to go public amid a rush by companies to build AI data centers ...
Last year turned out to be one of the best years for initial public offerings (IPOs) since 2014. In 2025, the U.S. had 353 IPOs, with 210 operating company IPOs, and $70 billion in capital raised.
SpaceX might not actually IPO in 2026. Can I interest you in a Starlink IPO instead?
The IPO process has faced delays since the first DRHP was filed in 2016. NSE sought the NOC multiple times, once in 2019, ...
Musk has called previous reports about a SpaceX IPO in 2026 "accurate." Other media outlets have indicated that the company ...
The No Objection Certificate (NOC) for the much-anticipated listing of the National Stock Exchange (NSE) is likely to be ...
By Arasu Kannagi Basil and Pritam Biswas Jan 20 (Reuters) - Clear Street recorded a 160% revenue jump in the first nine ...
Renaissance IPO ETF (IPO) is rated a buy, anticipating a surge in major IPOs through 2026 to fuel renewed investor interest.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results